Cargando…
Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas Disease
BACKGROUND: Chagas disease is due to the parasite Trypanosoma cruzi, a protist disseminated by a Triatome vector. This disease is endemic to Latin America and considered by WHO as one of the 17 world’s neglected diseases. In Europe and in North America, imported cases are also detected, due to migra...
Autores principales: | Granjon, Elodie, Dichtel-Danjoy, Marie-Laure, Saba, Esber, Sabino, Ester, Campos de Oliveira, Lea, Zrein, Maan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818036/ https://www.ncbi.nlm.nih.gov/pubmed/27035146 http://dx.doi.org/10.1371/journal.pntd.0004596 |
Ejemplares similares
-
Anti-Trypanosoma cruzi Cross-Reactive Antibodies Detected at High Rate in Non-Exposed Individuals Living in Non-Endemic Regions: Seroprevalence and Association to Other Viral Serologies
por: Saba, Esber S., et al.
Publicado: (2013) -
Trypanosoma-Cruzi Cross-Reactive Antibodies Longitudinal Follow-Up: A Prospective Observational Study in Hematopoietic Stem Cell Transplantation
por: Saba, Esber S., et al.
Publicado: (2015) -
A novel high performing multiplex immunoassay Multi-HTLV for serological confirmation and typing of HTLV infections
por: Marqué, Lola, et al.
Publicado: (2021) -
Assessment of multiplex Onchocerca volvulus peptide ELISA in non-endemic tropical regions
por: Lagatie, Ole, et al.
Publicado: (2019) -
Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure
por: Francisco, Amanda Fortes, et al.
Publicado: (2022)